Summary: Retatrutide and 5-Amino-1MQ are both unlicensed compounds in the UK retatrutide is an investigational triple incretin receptor agonist in clinical trials, whilst 5-Amino-1MQ is a research chemical with no approved human therapeutic use
As an investigational peptide, any legitimate clinical use involves a licensed provider, a prescription, and compounding through a licensed pharmacy
However , scientific proof for this mainly applies to people who already have a deficiency
Eden democratizes access to physician-guided treatments that support people in achieving their health goals, helping them feel and perform at their best. Begin your medically-led health & wellness journey today 1-on-1 guidance from US-based health experts No-cost consultations for continuous treatment optimization Fast & reliable deliveries with 24/7 support available Individual results may vary
These could include symptoms such as itching, a rash/hives, swelling especially around the face or throat, or difficulty breathing
